Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as
RSR13 may make tumor cells more sensitive to radiation therapy.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy to the
brain with or without RSR13 in treating patients who have brain metastases.